Defense World
08 Aug 2026, 07:32 UTC · 14w ago
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY
Impact · against what's priced in
The stock faces conflicting signals as a Q2 earnings beat and strong institutional accumulation are countered by significant price target cuts from Barclays and Citigroup. While insider buying suggests a floor near $10, the overall trend reflects a struggle between fundamental value and declining revenue growth.
- XRAY+0.10
No priced-in read yet
- In context
The stock is buoyed by an earnings beat ($0.52 EPS vs $0.35) and heavy institutional accumulation from firms like AQR and Southpoint, though this is tempered by a 4.1% year-over-year revenue decline and a Barclays price target cut to $9.00.
Read from the article alone

- XRAY
- analyst ratings
- healthcare equipment
- hedge funds
- insider trading
- institutional ownership
- medical instruments
- price target
- sec filing
Search tags




